Key result
The activation of the NLRP3 inflammasome plays a crucial role in the pathogenesis of cardiovascular diseases, making it a promising therapeutic target.
Why the study?
Activation of the NLRP3 inflammasome is associated with the pathogenesis of cardiovascular diseases, including hypertension, atherosclerosis, and heart failure.
This review highlights the critical role of the NLRP3 inflammasome in the pathogenesis of various cardiovascular diseases and its potential as a therapeutic target.
NLRP3-targeted therapy should not yet change practice; leaves open whether it adds value beyond IL-1 inhibition.
The NLRP3 inflammasome is a critical multiprotein signaling platform that activates caspase-1, leading to the maturation of pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18, and triggering inflammatory responses. Inflammation has been implicated as a significant process in cardiovascular diseases. The activation of the NLRP3 inflammasome is associated with the pathogenesis of cardiovascular diseases, including hypertension, atherosclerosis, and heart failure. This article provides an overview of the role, mechanisms, and potential therapeutic interventions related to the activation of the NLRP3 inflammasome in the occurrence and development of cardiovascular-related diseases.
No takes yet. Share an insight, caveat, or question.
Caocao et al. (2024) conducted a review in Cardiovascular diseases. NLRP3 inflammasome targeted therapies was evaluated. The activation of the NLRP3 inflammasome plays a crucial role in the pathogenesis of cardiovascular diseases, making it a promising therapeutic target.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: